Barclays’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-200
Closed -$1K 7479
2015
Q1
$1K Sell
200
-3,200
-94% -$22.4K ﹤0.01% 7033
2014
Q4
$17K Buy
+3,400
New +$18.3K ﹤0.01% 6429
2014
Q3
Sell
-200
Closed -$1K 8012
2014
Q2
$1K Hold
200
﹤0.01% 7561
2014
Q1
$1K Sell
200
-34,900
-99% -$257K ﹤0.01% 7532
2013
Q4
$246K Sell
35,100
-34,300
-49% -$255K ﹤0.01% 4812
2013
Q3
$486K Buy
69,400
+61,000
+726% +$474K ﹤0.01% 4149
2013
Q2
$55K Buy
+8,400
New +$52.8K ﹤0.01% 6253

Barclays's ELX Position: Q2 2015 in Review

Barclays sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 791,734 shares — an estimated $5.54M sold.

Barclays first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $5.54M in Q1 2015. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Barclays reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Barclays sold 791,734 EMULEX CORP shares in Q2 2015, an estimated $5.54M.
  • Barclays first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Barclays's EMULEX CORP position peaked at $5.54M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.